Literature DB >> 16169103

Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.

N J Young1, C J Thomas, I Thompson, M E Collins, J Brownlie.   

Abstract

Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) were investigated. cDNA encoding NS3 from type 1a BVDV was used to vaccinate five calves, another five calves remained unvaccinated. Three weeks after final vaccination animals were challenged intranasally with heterologous type 1a BVDV. Anti-NS3 antibodies were detected in only one animal post-vaccination. Partial protection from virus challenge was observed in the vaccinates. Virus was not isolated from nasal mucosa of two vaccinates, and virus clearance from nasal mucosa was faster in the vaccinates compared to the controls. While elevated rectal temperatures were evident in both groups 7 days post-challenge, the mean increase in the controls was twice that observed in the vaccinates. In conclusion, NS3 DNA vaccination induced humoral immunity in one calf, and prevented fever and virus establishment in the nasal mucosa in 2/5 calves, demonstrating the efficacy of NS3 vaccination, which may benefit future development of pestivirus and flavivirus vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169103     DOI: 10.1016/j.prevetmed.2005.08.013

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  6 in total

1.  Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.

Authors:  Simone M Costa; Anna Paula Yorio; Antônio J S Gonçalves; Mariana M Vidale; Emmerson C B Costa; Ronaldo Mohana-Borges; Marcia A Motta; Marcos S Freire; Ada M B Alves
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

2.  Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.

Authors:  M L Hurtado-Melgoza; A Ramos-Ligonio; L M Álvarez-Rodríguez; T Meza-Menchaca; A López-Monteon
Journal:  J Biomed Sci       Date:  2016-12-01       Impact factor: 8.410

3.  Recombinant E2 protein enhances protective efficacy of inactivated bovine viral diarrhea virus 2 vaccine in a goat model.

Authors:  Yao-Chi Chung; Li-Ting Cheng; Jia-Yu Zhang; Yue-Jyun Wu; Shyh-Shyan Liu; Chun-Yen Chu
Journal:  BMC Vet Res       Date:  2018-06-19       Impact factor: 2.741

4.  Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.

Authors:  Neha Sangewar; Wisam Hassan; Shehnaz Lokhandwala; Jocelyn Bray; Rachel Reith; Mary Markland; Huldah Sang; Jianxiu Yao; Bailey Fritz; Suryakant D Waghela; Karim W Abdelsalam; Christopher C L Chase; Waithaka Mwangi
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 5.  Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis.

Authors:  Victor Riitho; Rebecca Strong; Magdalena Larska; Simon P Graham; Falko Steinbach
Journal:  Viruses       Date:  2020-10-06       Impact factor: 5.048

Review 6.  Recent Development of Ruminant Vaccine Against Viral Diseases.

Authors:  Sk Mohiuddin Choudhury; XuSheng Ma; Wen Dang; YuanYuan Li; HaiXue Zheng
Journal:  Front Vet Sci       Date:  2021-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.